Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

An EU court upholds decision that Google unfairly boosted its shopping services, likely influencing future cases under EU and UK competition laws.

More bad news for Venu Sports: The proposed sports streaming service will go to court with Fubo in October, kicking a potential launch further down the road.

GenAI is testing limits of IT teams, sparking executive concerns: As companies focus on AI, leaders fear basic services may be neglected, raising questions about long-term stability and system support.

In response to the CrowdStrike breach, Microsoft limits access to its Windows kernel, but vendors worry the new rules may stifle competition.

“If you’re a marketer looking to reach Gen Z, you need to be everywhere,” our analyst Blake Droesch said. Although Gen Z is known to spend a significant amount of time on social media, tapped into newer buying behavior such as social commerce, they also rely on physical stores. Here are three ways Gen Z’s path to purchase stands out.

Consumers may be concerned about the economy, but the outlook is good for ad spend in the final months of 2024. The share of advertisers concerned about a slowing US economy dropped 11 percentage points (from 49% to 38%) between November 2023 and August 2024, according to the Interactive Advertising Bureau (IAB). Retail media’s popularity, an influx of value-based messaging, high political ad spend, and connected TV (CTV) monetization will boost the ad industry the rest of 2024.

Senate ramps up social media regulation for teens: Two landmark bills that require more protections for minors will move to the House.

A look at the psychology behind payments: A Mastercard-sponsored study took a behavioral science approach to understanding the reasons—conscious and unconscious—that influence consumer payment choices and help payment providers guide their behaviors.

Conference panelists discussed changes in the maturing industry as it ripples across the payments space

Users can now add their US passports and more transit cards to their wallets, and Google is getting more companies to accept these passes

Deloitte expects holiday sales to grow 2.3% to 3.3% this year: That’s well short of our forecast, which projects 4.8% growth. Both reflect the complicated environment ahead.

Kroger benefited from shoppers’ deal-seeking behaviors in Q2: Despite a difficult operating environment, the grocer won over consumers with lower prices and expanded private label selections.

Inclusive brands, exclusive growth: Beauty companies that champion inclusion unlock new customer segments and drive higher sales, a Circana and SeeMee Index study shows.

General Mills sharpens its focus on high-margin core brands: The company agreed to sell its North American yogurt business, which includes the Yoplait brand, for $2.1 billion.

Each patient generation takes a unique path on their health journey: We unpack the channels where patients begin their health journeys and explore how marketers can tailor their engagement strategies to best reach each generation.

Noom gets into compounded GLP-1s with a taper-off guarantee: It’s building a weight loss program around the idea that patients will eventually want to stop taking the medications. We explore the pros and cons.

FDA warns AbbVie for misleading TV ad ft. Serena Williams: Pharma marketers—particularly those who work with celebrities—ought to pay close attention to the regulator’s assertions.